Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Research in the lab of Quinn P. Peterson, Ph.D., aims to build human islets as a cell replacement therapy for type 1 diabetes. The transplantation of these "designer" islets may restore the ability to produce insulin and regulate blood glucose in patients with type 1 diabetes.
For more information about islet regeneration and the work conducted by Dr. Peterson, visit the Center for Regenerative Biotherapeutics' Islet Regeneration Program.
The transplantation of stem cell-derived islets provides a promising approach to treating type 1 diabetes. Successful transplantation of these cells may allow people with type 1 diabetes to produce their own insulin, remove the need for insulin injections and blood glucose monitoring, and eliminate complications from type 1 diabetes.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.